> top > docs > PMC:7068164 > annotations

PMC:7068164 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2 15-39 Disease denotes coronavirus disease 2019 MESH:C000657245
3 41-49 Disease denotes COVID-19 MESH:C000657245
7 418-421 Gene denotes age Gene:5973
8 148-156 Disease denotes COVID-19 MESH:C000657245
9 387-395 Disease denotes infected MESH:D007239
19 736-753 Species denotes novel coronavirus Tax:2697049
20 761-808 Species denotes severe acute respiratory syndrome coronavirus 2 Tax:2697049
21 810-820 Species denotes SARS-CoV-2 Tax:2697049
22 896-906 Species denotes SARS-CoV-2 Tax:2697049
23 589-598 Disease denotes pneumonia MESH:D011014
24 922-946 Disease denotes coronavirus disease 2019 MESH:C000657245
25 948-956 Disease denotes COVID-19 MESH:C000657245
26 1192-1200 Disease denotes COVID-19 MESH:C000657245
27 1393-1402 Disease denotes infection MESH:D007239
38 2645-2655 Species denotes SARS-CoV-2 Tax:2697049
39 2780-2790 Species denotes SARS-CoV-2 Tax:2697049
40 2832-2843 Species denotes coronavirus Tax:11118
41 3032-3042 Species denotes SARS-CoV-2 Tax:2697049
42 1659-1667 Disease denotes COVID-19 MESH:C000657245
43 1853-1861 Disease denotes COVID-19 MESH:C000657245
44 2084-2092 Disease denotes COVID-19 MESH:C000657245
45 2324-2332 Disease denotes COVID-19 MESH:C000657245
46 2372-2391 Disease denotes symptoms of disease MESH:D009202
47 2593-2613 Disease denotes SARS-CoV-2 infection MESH:C000657245
50 3425-3433 Disease denotes COVID-19 MESH:C000657245
51 3502-3506 Disease denotes died MESH:D003643
53 3769-3774 Disease denotes death MESH:D003643
55 4049-4057 Disease denotes COVID-19 MESH:C000657245
57 4181-4205 Disease denotes coronavirus disease 2019 MESH:C000657245
63 4541-4550 Disease denotes infection MESH:D007239
64 4801-4809 Disease denotes infected MESH:D007239
65 4943-4951 Disease denotes infected MESH:D007239
66 5350-5358 Disease denotes infected MESH:D007239
67 5468-5476 Disease denotes infected MESH:D007239
71 5857-5860 Gene denotes age Gene:5973
72 5503-5506 Gene denotes age Gene:5973
73 5950-5959 Disease denotes infection MESH:D007239
81 6288-6291 Gene denotes Age Gene:5973
82 6224-6232 Disease denotes infected MESH:D007239
83 6260-6268 Disease denotes infected MESH:D007239
84 6487-6493 Disease denotes ND ND MESH:C537849
85 6510-6516 Disease denotes ND ND MESH:C537849
86 6586-6606 Disease denotes ND ND ND     Fever MESH:C537849
87 6612-6653 Disease denotes ND ND     Cough 14 ND ND     Weakness MESH:C537849
89 6096-6104 Disease denotes COVID-19 MESH:C000657245
91 6942-6966 Disease denotes coronavirus disease 2019 MESH:C000657245
94 7166-7174 Disease denotes infected MESH:D007239
95 7195-7203 Disease denotes infected MESH:D007239
97 7779-7787 Disease denotes infected MESH:D007239
110 8380-8385 Disease denotes fever MESH:D005334
111 8399-8404 Disease denotes cough MESH:D003371
112 8424-8432 Disease denotes weakness MESH:D018908
113 8472-8481 Disease denotes headaches MESH:D006261
114 8493-8504 Disease denotes sore throat MESH:D010608
115 8510-8521 Disease denotes rhinorrhoea
116 8527-8546 Disease denotes shortness of breath MESH:D004417
117 8552-8559 Disease denotes myalgia MESH:D063806
118 8565-8574 Disease denotes diarrhoea MESH:D003967
119 8583-8589 Disease denotes nausea MESH:D009325
120 8595-8600 Disease denotes Fever MESH:D005334
121 8758-8779 Disease denotes respiratory infection MESH:D012141
125 9024-9029 Disease denotes obese MESH:D009765
126 9055-9070 Disease denotes cardiac disease MESH:D006331
127 9103-9110 Disease denotes dyspnea MESH:D004417
131 9295-9310 Disease denotes viral pneumonia
132 9444-9448 Disease denotes died MESH:D003643
133 9463-9467 Disease denotes died MESH:D003643
136 9915-9919 Gene denotes RdRp Gene:43740578
137 9944-9945 Gene denotes N Gene:43740575
141 10300-10308 Disease denotes COVID-19 MESH:C000657245
142 10530-10536 Disease denotes deaths MESH:D003643
143 10599-10605 Disease denotes deaths MESH:D003643
147 11055-11061 Species denotes People Tax:9606
148 10824-10833 Disease denotes infection MESH:D007239
149 12333-12342 Disease denotes infection MESH:D007239
153 12726-12734 Disease denotes COVID-19 MESH:C000657245
154 13035-13043 Disease denotes COVID-19 MESH:C000657245
155 13087-13109 Disease denotes respiratory infections MESH:D012141
160 13310-13331 Disease denotes respiratory infection MESH:D012141
161 13412-13417 Disease denotes fever MESH:D005334
162 13453-13458 Disease denotes fever MESH:D005334
163 13583-13588 Disease denotes fever MESH:D005334
167 13840-13843 Gene denotes age Gene:5973
168 13914-13923 Disease denotes infection MESH:D007239
169 14264-14274 Disease denotes infections MESH:D007239
171 14374-14382 Disease denotes COVID-19 MESH:C000657245
176 15519-15529 Species denotes SARS-CoV-2 Tax:2697049
177 14799-14809 Disease denotes infections MESH:D007239
178 14854-14863 Disease denotes infection MESH:D007239
179 15175-15180 Disease denotes death MESH:D003643
181 16243-16252 Disease denotes infection MESH:D007239
186 18048-18050 Gene denotes CS Gene:1431
187 17706-17708 Disease denotes GS MESH:D011125
188 17795-17797 Disease denotes GS MESH:D011125
189 17822-17824 Disease denotes GS MESH:D011125

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 6699-6705 Body_part denotes throat http://purl.org/sig/ont/fma/fma228738
T2 8498-8504 Body_part denotes throat http://purl.org/sig/ont/fma/fma228738
T3 8621-8625 Body_part denotes sole http://purl.org/sig/ont/fma/fma25000
T4 9856-9860 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T5 9885-9888 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T6 9899-9902 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T7 9921-9925 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T8 9947-9951 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T9 10088-10094 Body_part denotes throat http://purl.org/sig/ont/fma/fma228738
T10 10127-10133 Body_part denotes sputum http://purl.org/sig/ont/fma/fma312401
T11 17987-17989 Body_part denotes AG http://purl.org/sig/ont/fma/fma61898
T12 18048-18050 Body_part denotes CS http://purl.org/sig/ont/fma/fma284995

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 6699-6705 Body_part denotes throat http://purl.obolibrary.org/obo/UBERON_0000341
T2 8498-8504 Body_part denotes throat http://purl.obolibrary.org/obo/UBERON_0000341
T3 10088-10094 Body_part denotes throat http://purl.obolibrary.org/obo/UBERON_0000341
T4 10127-10133 Body_part denotes sputum http://purl.obolibrary.org/obo/UBERON_0007311

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 15-39 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T2 41-49 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 148-156 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 589-598 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T5 761-808 Disease denotes severe acute respiratory syndrome coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T6 761-794 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T7 810-818 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T8 896-904 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T9 922-946 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T10 948-956 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T11 1192-1200 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 1393-1402 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T13 1659-1667 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T14 1853-1861 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T15 2084-2092 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T16 2324-2332 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T17 2593-2601 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T18 2604-2613 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T19 2645-2653 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T20 2780-2788 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T21 3032-3040 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T22 3425-3433 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T23 4049-4057 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T24 4171-4179 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T25 4181-4205 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T26 4541-4550 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T27 5950-5959 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T28 6096-6104 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T29 6694-6705 Disease denotes Sore throat http://purl.obolibrary.org/obo/MONDO_0002258
T30 6932-6940 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T31 6942-6966 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T32 8493-8504 Disease denotes sore throat http://purl.obolibrary.org/obo/MONDO_0002258
T33 8565-8574 Disease denotes diarrhoea http://purl.obolibrary.org/obo/MONDO_0001673
T34 8758-8779 Disease denotes respiratory infection http://purl.obolibrary.org/obo/MONDO_0024355
T35 8770-8779 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T36 9055-9070 Disease denotes cardiac disease http://purl.obolibrary.org/obo/MONDO_0005267
T37 9295-9310 Disease denotes viral pneumonia http://purl.obolibrary.org/obo/MONDO_0006012
T38 9301-9310 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T39 10300-10308 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T40 10824-10833 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T41 12333-12342 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T42 12726-12734 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T43 13035-13043 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T44 13087-13109 Disease denotes respiratory infections http://purl.obolibrary.org/obo/MONDO_0024355
T45 13310-13331 Disease denotes respiratory infection http://purl.obolibrary.org/obo/MONDO_0024355
T46 13322-13331 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T47 13914-13923 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T48 14264-14277 Disease denotes infections in http://purl.obolibrary.org/obo/MONDO_0005550
T49 14374-14382 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T50 14799-14809 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T51 14854-14863 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T52 15246-15255 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T53 15473-15482 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T54 15519-15527 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T55 15875-15885 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T56 16243-16252 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T57 17177-17185 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T58 17638-17640 Disease denotes EB http://purl.obolibrary.org/obo/MONDO_0006541
T59 17706-17708 Disease denotes GS http://purl.obolibrary.org/obo/MONDO_0005773
T60 17714-17716 Disease denotes EB http://purl.obolibrary.org/obo/MONDO_0006541
T61 17722-17724 Disease denotes NB http://purl.obolibrary.org/obo/MONDO_0005072
T62 17795-17797 Disease denotes GS http://purl.obolibrary.org/obo/MONDO_0005773
T63 17822-17824 Disease denotes GS http://purl.obolibrary.org/obo/MONDO_0005773
T64 17834-17836 Disease denotes NB http://purl.obolibrary.org/obo/MONDO_0005072
T65 17842-17844 Disease denotes EB http://purl.obolibrary.org/obo/MONDO_0006541
T66 17898-17900 Disease denotes JP http://purl.obolibrary.org/obo/MONDO_0010820
T67 18052-18054 Disease denotes AM http://purl.obolibrary.org/obo/MONDO_0020320
T68 18056-18059 Disease denotes DLB http://purl.obolibrary.org/obo/MONDO_0007488
T69 18065-18068 Disease denotes SBS http://purl.obolibrary.org/obo/MONDO_0011526
T70 18085-18087 Disease denotes BL http://purl.obolibrary.org/obo/MONDO_0007243
T71 18129-18131 Disease denotes NB http://purl.obolibrary.org/obo/MONDO_0005072
T72 18133-18135 Disease denotes LS http://purl.obolibrary.org/obo/MONDO_0009723

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 186-188 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T2 444-448 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T3 444-448 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male
T4 576-577 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T5 734-735 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 907-910 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T7 987-992 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T8 1094-1106 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T9 1130-1133 http://purl.obolibrary.org/obo/CLO_0001000 denotes 3-5
T10 1313-1314 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T11 1498-1500 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T12 1644-1645 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T13 1767-1770 http://purl.obolibrary.org/obo/PR_000001343 denotes aim
T14 1999-2009 http://purl.obolibrary.org/obo/BFO_0000030 denotes objectives
T15 2300-2301 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T16 2435-2440 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T17 2531-2532 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T18 2552-2553 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T19 2663-2668 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T20 2724-2725 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T21 2744-2745 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T22 2768-2775 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T23 2826-2827 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T24 2828-2831 http://purl.obolibrary.org/obo/NCBITaxon_9596 denotes pan
T25 3193-3200 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T26 3279-3286 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T27 4167-4168 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T28 4169-4170 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T29 4225-4237 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T30 4239-4240 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T31 4455-4456 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T32 4639-4641 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T33 4749-4751 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T34 4991-4992 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T35 5035-5036 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T36 5568-5572 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T37 5568-5572 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male
T38 5600-5604 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T39 5600-5604 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male
T40 5657-5662 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T41 5657-5662 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T42 5717-5722 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T43 5717-5722 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T44 5807-5811 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T45 5869-5874 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T46 5869-5874 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T47 5876-5878 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T48 5886-5893 http://purl.obolibrary.org/obo/UBERON_0003100 denotes females
T49 5921-5925 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T50 6164-6165 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T51 6335-6337 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T52 6366-6370 http://purl.obolibrary.org/obo/CLO_0001407 denotes 5 2
T53 6397-6401 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Male
T54 6397-6401 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Male
T55 6407-6412 http://purl.obolibrary.org/obo/CLO_0001079 denotes 14 8
T56 6422-6428 http://purl.obolibrary.org/obo/UBERON_0003100 denotes Female
T57 6461-6463 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T58 6898-6902 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T59 7015-7027 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T60 7029-7030 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T61 7101-7102 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T62 7115-7119 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T63 7216-7217 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T64 7352-7354 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T65 7625-7626 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T66 7815-7816 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T67 8004-8005 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T68 8060-8061 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T69 8210-8216 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T70 8255-8261 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T71 9182-9183 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T72 9628-9629 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T73 9836-9841 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T74 9856-9860 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T75 9864-9865 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T76 9876-9880 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T77 9921-9925 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T78 9947-9951 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T79 9997-10003 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T80 10022-10024 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T81 10143-10144 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T82 10179-10180 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T83 10222-10223 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T84 10413-10414 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T85 10538-10540 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T86 11111-11112 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T87 11147-11153 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T88 11704-11705 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T89 11774-11775 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T90 12374-12375 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T91 12505-12512 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T92 12647-12650 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T93 12780-12781 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T94 12864-12871 http://purl.obolibrary.org/obo/UBERON_0000473 denotes Testing
T95 13063-13070 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T96 13209-13211 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T97 14140-14141 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T98 14831-14833 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T99 15332-15333 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T100 15646-15651 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T101 16115-16116 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T102 16185-16188 http://purl.obolibrary.org/obo/PR_000001343 denotes aim
T103 16388-16389 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T104 16504-16505 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T105 17042-17045 http://purl.obolibrary.org/obo/CLO_0008190 denotes Per
T106 17638-17640 http://purl.obolibrary.org/obo/CLO_0002867 denotes EB
T107 17714-17716 http://purl.obolibrary.org/obo/CLO_0002867 denotes EB
T108 17842-17844 http://purl.obolibrary.org/obo/CLO_0002867 denotes EB
T109 17975-17977 http://purl.obolibrary.org/obo/CLO_0007622 denotes MD
T110 17995-17997 http://purl.obolibrary.org/obo/CLO_0008491 denotes PS
T111 18089-18091 http://purl.obolibrary.org/obo/CLO_0003384 denotes FR
T112 18093-18095 http://purl.obolibrary.org/obo/CLO_0037161 denotes EN

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 444-448 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780
T2 5568-5572 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780
T3 5600-5604 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780
T4 6473-6475 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T5 6487-6489 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T6 6491-6493 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T7 6510-6512 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T8 6514-6516 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T9 6586-6588 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T10 6590-6592 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T11 6594-6596 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T12 6612-6614 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T13 6616-6618 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T14 6634-6636 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T15 6638-6640 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T16 6658-6660 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T17 6662-6664 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T18 6683-6685 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T19 6687-6689 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T20 6710-6712 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T21 6714-6716 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T22 6737-6739 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T23 6741-6743 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T24 6772-6774 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T25 6776-6778 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T26 6845-6847 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T27 6929-6931 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T28 6968-6970 Chemical denotes ND http://purl.obolibrary.org/obo/CHEBI_73419
T29 17638-17640 Chemical denotes EB http://purl.obolibrary.org/obo/CHEBI_53197
T30 17706-17708 Chemical denotes GS http://purl.obolibrary.org/obo/CHEBI_73516
T31 17714-17716 Chemical denotes EB http://purl.obolibrary.org/obo/CHEBI_53197
T32 17795-17797 Chemical denotes GS http://purl.obolibrary.org/obo/CHEBI_73516
T33 17822-17824 Chemical denotes GS http://purl.obolibrary.org/obo/CHEBI_73516
T34 17842-17844 Chemical denotes EB http://purl.obolibrary.org/obo/CHEBI_53197
T35 17894-17896 Chemical denotes DP http://purl.obolibrary.org/obo/CHEBI_137245
T36 17902-17904 Chemical denotes RP http://purl.obolibrary.org/obo/CHEBI_141419
T37 17906-17908 Chemical denotes SO http://purl.obolibrary.org/obo/CHEBI_45822
T38 17975-17977 Chemical denotes MD http://purl.obolibrary.org/obo/CHEBI_74699
T39 17979-17981 Chemical denotes CC http://purl.obolibrary.org/obo/CHEBI_28940
T40 17983-17985 Chemical denotes VE http://purl.obolibrary.org/obo/CHEBI_75011
T41 17987-17989 Chemical denotes AG http://purl.obolibrary.org/obo/CHEBI_27569|http://purl.obolibrary.org/obo/CHEBI_40618|http://purl.obolibrary.org/obo/CHEBI_73757
T44 17995-17997 Chemical denotes PS http://purl.obolibrary.org/obo/CHEBI_18303|http://purl.obolibrary.org/obo/CHEBI_53276|http://purl.obolibrary.org/obo/CHEBI_73648
T47 18039-18041 Chemical denotes LF http://purl.obolibrary.org/obo/CHEBI_73585
T48 18048-18050 Chemical denotes CS http://purl.obolibrary.org/obo/CHEBI_73462
T49 18081-18083 Chemical denotes MV http://purl.obolibrary.org/obo/CHEBI_73616
T50 18089-18091 Chemical denotes FR http://purl.obolibrary.org/obo/CHEBI_73632
T51 18111-18113 Chemical denotes FP http://purl.obolibrary.org/obo/CHEBI_74750
T52 18133-18135 Chemical denotes LS http://purl.obolibrary.org/obo/CHEBI_73523
T53 18146-18148 Chemical denotes MP http://purl.obolibrary.org/obo/CHEBI_73612

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 12184-12195 http://purl.obolibrary.org/obo/GO_0065007 denotes Regulations
T2 15937-15949 http://purl.obolibrary.org/obo/GO_0000003 denotes reproduction

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-109 Sentence denotes First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
T2 111-119 Sentence denotes Abstract
T3 120-202 Sentence denotes In the WHO European Region, COVID-19 surveillance was implemented 27 January 2020.
T4 203-238 Sentence denotes We detail the first European cases.
T5 239-300 Sentence denotes As at 21 February, nine European countries reported 47 cases.
T6 301-405 Sentence denotes Among 38 cases studied, 21 were linked to two clusters in Germany and France, 14 were infected in China.
T7 406-449 Sentence denotes Median case age was 42 years; 25 were male.
T8 450-535 Sentence denotes Late detection of the clusters’ index cases delayed isolation of further local cases.
T9 536-574 Sentence denotes As at 5 March, there were 4,250 cases.
T10 576-670 Sentence denotes A cluster of pneumonia of unknown origin was identified in Wuhan, China, in December 2019 [1].
T11 671-861 Sentence denotes On 12 January 2020, Chinese authorities shared the sequence of a novel coronavirus termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolated from some clustered cases [2].
T12 862-958 Sentence denotes Since then, the disease caused by SARS-CoV-2 has been named coronavirus disease 2019 (COVID-19).
T13 959-1135 Sentence denotes As at 21 February 2020, the virus had spread rapidly mostly within China but also to 28 other countries, including in the World Health Organization (WHO) European Region [3-5].
T14 1136-1293 Sentence denotes Here we describe the epidemiology of the first cases of COVID-19 in this region, excluding cases reported in the United Kingdom (UK), as at 21 February 2020.
T15 1294-1453 Sentence denotes The study includes a comparison between cases detected among travellers from China and cases whose infection was acquired due to subsequent local transmission.
T16 1455-1494 Sentence denotes Surveillance in the WHO European Region
T17 1495-1754 Sentence denotes On 27 January 2020, the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe asked countries to complete a WHO standard COVID-19 case report form for all confirmed and probable cases according to WHO criteria [6-8].
T18 1755-1981 Sentence denotes The overall aim of surveillance at this time was to support the global strategy of containment of COVID-19 with rapid identification and follow-up of cases linked to affected countries in order to minimise onward transmission.
T19 1982-2198 Sentence denotes The surveillance objectives were to: describe the key epidemiological and clinical characteristics of COVID-19 cases detected in Europe; inform country preparedness; and improve further case detection and management.
T20 2199-2476 Sentence denotes Data collected included demographics, history of recent travel to affected areas, close contact with a probable or confirmed COVID-19 case, underlying conditions, signs and symptoms of disease at onset, type of specimens from which the virus was detected, and clinical outcome.
T21 2477-2854 Sentence denotes The WHO case definition was adopted for surveillance: a confirmed case was a person with laboratory confirmation of SARS-CoV-2 infection (ECDC recommended two separate SARS-CoV-2 RT-PCR tests), irrespective of clinical signs and symptoms, whereas a probable case was a suspect case for whom testing for SARS-CoV-2 was inconclusive or positive using a pan-coronavirus assay [8].
T22 2855-3210 Sentence denotes By 31 January 2020, 47 laboratories in 31 countries, including 38 laboratories in 24 European Union and European Economic Area (EU/EEA) countries, had diagnostic capability for SARS-CoV-2 available (close to 60% of countries in the WHO European Region), with cross-border shipment arrangements in place for many of those lacking domestic testing capacity.
T23 3211-3317 Sentence denotes The remaining six EU/EEA countries were expected to have diagnostic testing available by mid-February [9].
T24 3319-3369 Sentence denotes Epidemiology of first cases in the European Region
T25 3370-3511 Sentence denotes As at 09:00 on 21 February 2020, 47 confirmed cases of COVID-19 were reported in the WHO European Region and one of these cases had died [4].
T26 3512-3614 Sentence denotes Data on 38 of these cases (i.e. all except the nine reported in the UK) are included in this analysis.
T27 3615-3758 Sentence denotes The first three cases detected were reported in France on 24 January 2020 and had onset of symptoms on 17, 19 and 23 January respectively [10].
T28 3759-3813 Sentence denotes The first death was reported on 15 February in France.
T29 3814-3876 Sentence denotes As at 21 February, nine countries had reported cases (Figure):
T30 3877-4013 Sentence denotes Belgium (1), Finland (1), France (12), Germany (16), Italy (3), Russia (2), Spain (2), Sweden (1) and the UK (9 – not included further).
T31 4014-4170 Sentence denotes Figure Epidemic curve of reported COVID-19 cases by date of symptom onset, or date of notification, WHO European Region, as at 21 February 2020 (n = 38)a,b
T32 4171-4211 Sentence denotes COVID-19: coronavirus disease 2019; WHO:
T33 4212-4238 Sentence denotes World Health Organization.
T34 4239-4331 Sentence denotes a Four cases were reported by Germany with unknown date of onset and unknown symptomatology.
T35 4332-4387 Sentence denotes Belgium and France reported one asymptomatic case each.
T36 4388-4454 Sentence denotes These cases are displayed according to their date of notification.
T37 4455-4527 Sentence denotes b The figure does not include nine cases reported in the United Kingdom.
T38 4528-4835 Sentence denotes The place of infection (assessed at national level based on an incubation period presumed to be up to 14 days [11], travel history and contact with probable or confirmed cases as per the case definition) was reported for 35 cases (missing for three cases), of whom 14 were infected in China (Hubei province:
T39 4836-4914 Sentence denotes 10 cases; Shandong province: one case; province not reported for three cases).
T40 4915-4962 Sentence denotes The remaining 21 cases were infected in Europe.
T41 4963-5077 Sentence denotes Of these, 14 were linked to a cluster in Bavaria, Germany, and seven to a cluster in Haute-Savoie, France [12,13].
T42 5078-5228 Sentence denotes Cases from the Bavarian cluster were reported from Germany and Spain, whereas cases from the Haute-Savoie cluster were reported from France and Spain.
T43 5229-5405 Sentence denotes Cases linked to the Haute Savoie cluster were also detected in the UK, including the index case of this cluster, who was infected in Singapore before travelling to France [14].
T44 5406-5491 Sentence denotes The index cases for the cluster in Bavaria was reported to be infected in China [15].
T45 5492-5543 Sentence denotes The median age of the 38 cases was 42 years (range:
T46 5544-5581 Sentence denotes 2–81 years) and 25 were male (Table).
T47 5582-5822 Sentence denotes The proportion of male cases was higher among cases acquired in Europe (14 males of 21 cases) compared with those acquired in China (8 males of 14 cases) although the difference was not statistically significant (chi-squared test: p = 0.6).
T48 5823-5875 Sentence denotes There was no difference in median age by sex (males:
T49 5876-5894 Sentence denotes 45 years; females:
T50 5895-6010 Sentence denotes 38 years, k-sample median test, p = 1.0) or by whether infection was acquired in Europe or not (acquired in Europe:
T51 6011-6039 Sentence denotes 47 years; acquired in China:
T52 6040-6059 Sentence denotes 38 years, p = 0.2).
T53 6060-6165 Sentence denotes Table Characteristics of confirmed COVID-19 cases, WHO European Region, as at 21 February 2020 (n = 38)a
T54 6166-6287 Sentence denotes Characteristics Number of cases overall Number of cases infected in Europe Number of cases infected in China p valueb
T55 6288-6306 Sentence denotes Age range in years
T56 6307-6330 Sentence denotes     0–17 4 3 0 0.08
T57 6331-6351 Sentence denotes     18–49 24 13 9
T58 6352-6370 Sentence denotes     50–64 7 5 2
T59 6371-6388 Sentence denotes     ≥ 65 3 0 3
T60 6389-6392 Sentence denotes Sex
T61 6393-6417 Sentence denotes     Male 25 14 8 0.6
T62 6418-6438 Sentence denotes     Female 13 7 6
T63 6439-6451 Sentence denotes Hospitalised
T64 6452-6475 Sentence denotes     Yes 35 21 14 ND
T65 6476-6493 Sentence denotes     No 2 ND ND
T66 6494-6516 Sentence denotes     Unknown 1 ND ND
T67 6517-6564 Sentence denotes Symptomsc (31 cases with available information)
T68 6565-6596 Sentence denotes     Asymptomatic 2 ND ND ND
T69 6597-6618 Sentence denotes     Fever 20 ND ND
T70 6619-6640 Sentence denotes     Cough 14 ND ND
T71 6641-6664 Sentence denotes     Weakness 8 ND ND
T72 6665-6689 Sentence denotes     Headaches 6 ND ND
T73 6690-6716 Sentence denotes     Sore throat 2 ND ND
T74 6717-6743 Sentence denotes     Rhinorrhoea 2 ND ND
T75 6744-6778 Sentence denotes     Shortness of breath 2 ND ND
T76 6779-6847 Sentence denotes Mean days from onset to hospitalisation(29 cases) 3.7 4.6 2.5 ND
T77 6848-6931 Sentence denotes Mean days from onset to first positive laboratory test(16 cases) 5.1 6.5 5.2 ND
T78 6932-7001 Sentence denotes COVID-19: coronavirus disease 2019; ND: not determined or known; WHO:
T79 7002-7028 Sentence denotes World Health Organization.
T80 7029-7100 Sentence denotes a The Table does not include nine cases reported in the United Kingdom.
T81 7101-7213 Sentence denotes b Chi-squared test for difference in distributions between cases infected in Europe and those infected in China.
T82 7214-7263 Sentence denotes c A single case could have more than one symptom.
T83 7264-7314 Sentence denotes Only symptoms reported by two or more cases shown.
T84 7315-7523 Sentence denotes All but two cases were hospitalised (35 of 37 where information on hospitalisation was reported), although it is likely that most were hospitalised to isolate the person rather than because of severe disease.
T85 7524-7668 Sentence denotes The time from onset of symptoms to hospitalisation (and isolation) ranged between 0 and 10 days with a mean of 3.7 days (reported for 29 cases).
T86 7669-7798 Sentence denotes The mean number of days to hospitalisation was 2.5 days for cases imported from China, but 4.6 days for those infected in Europe.
T87 7799-7907 Sentence denotes This was mostly a result of delays in identifying the index cases of the two clusters in France and Germany.
T88 7908-8096 Sentence denotes In the German cluster, for example, the first three cases detected locally were hospitalised in a mean of 5.7 days, whereas the following six took only a mean of 2 days to be hospitalised.
T89 8097-8159 Sentence denotes Symptoms at the point of diagnosis were reported for 31 cases.
T90 8160-8226 Sentence denotes Two cases were asymptomatic and remained so until tested negative.
T91 8227-8346 Sentence denotes The asymptomatic cases were tested as part of screening following repatriation and during contact tracing respectively.
T92 8347-8433 Sentence denotes Of the remaining 29, 20 reported fever, 14 reported cough and eight reported weakness.
T93 8434-8594 Sentence denotes Additional symptoms reported included headaches (6 cases), sore throat (2), rhinorrhoea (2), shortness of breath (2), myalgia (1), diarrhoea (1) and nausea (1).
T94 8595-8649 Sentence denotes Fever was reported as the sole symptom for nine cases.
T95 8650-8895 Sentence denotes In 16 of 29 symptomatic cases, the symptoms at diagnosis were consistent with the case definition for acute respiratory infection [16], although it is possible that cases presented additional symptoms after diagnosis and these were not reported.
T96 8896-9071 Sentence denotes Data on pre-existing conditions were reported for seven cases; five had no pre-existing conditions while one was reported to be obese and one had pre-existing cardiac disease.
T97 9072-9154 Sentence denotes No data on clinical signs e.g. dyspnea etc. were reported for any of the 38 cases.
T98 9155-9311 Sentence denotes All hospitalised cases had a benign clinical evolution except four, two reported in Italy and two reported in France, all of whom developed viral pneumonia.
T99 9312-9449 Sentence denotes All three cases who were aged 65 years or over were admitted to intensive care and required respiratory support and one French case died.
T100 9450-9564 Sentence denotes The case who died was hospitalised for 21 days and required intensive care and mechanical ventilation for 19 days.
T101 9565-9655 Sentence denotes The duration of hospitalisation was reported for 16 cases with a median of 13 days (range:
T102 9656-9667 Sentence denotes 8–23 days).
T103 9668-9727 Sentence denotes As at 21 February 2020, four cases were still hospitalised.
T104 9729-9749 Sentence denotes Laboratory diagnosis
T105 9750-9977 Sentence denotes All cases were confirmed according to specific assays targeting at least two separate genes (envelope (E) gene as a screening test and RNA-dependent RNA polymerase (RdRp) gene or nucleoprotein (N) gene for confirmation) [8,17].
T106 9978-10031 Sentence denotes The specimen types tested were reported for 27 cases:
T107 10032-10255 Sentence denotes 15 had positive nasopharyngeal swabs, nine had positive throat swabs, three cases had positive sputum, two had a positive nasal swab, one case had a positive nasopharyngeal aspirate and one a positive endotracheal aspirate.
T108 10257-10267 Sentence denotes Discussion
T109 10268-10362 Sentence denotes As at 09:00 on 21 February, few COVID-19 cases had been detected in Europe compared with Asia.
T110 10363-10542 Sentence denotes However the situation is rapidly developing, with a large outbreak recently identified in northern Italy, with transmission in several municipalities and at least two deaths [18].
T111 10543-10666 Sentence denotes As at 5 March 2020, there are 4,250 cases including 113 deaths reported among 38 countries in the WHO European region [19].
T112 10667-10892 Sentence denotes In our analysis of early cases, we observed transmission in two broad contexts: sporadic cases among travellers from China (14 cases) and cases who acquired infection due to subsequent local transmission in Europe (21 cases).
T113 10893-11054 Sentence denotes Our analysis shows that the time from symptom onset to hospitalisation/case isolation was about 3 days longer for locally acquired cases than for imported cases.
T114 11055-11334 Sentence denotes People returning from affected areas are likely to have a low threshold to seek care and be tested when symptomatic, however delays in identifying the index cases of the two clusters in France and Germany meant that locally acquired cases took longer to be detected and isolated.
T115 11335-11607 Sentence denotes Once the exposure is determined and contacts identified and quarantined (171 contacts in France and 200 in Germany for the clusters in Haute-Savoie and Bavaria, respectively), further cases are likely to be rapidly detected and isolated when they develop symptoms [15,20].
T116 11608-11791 Sentence denotes In the German cluster, for example, the first three cases detected locally were hospitalised in a mean of 5.7 days, whereas the following six were hospitalised after a mean of 2 days.
T117 11792-12042 Sentence denotes Locally acquired cases require significant resources for contact tracing and quarantine, and countries should be prepared to allocate considerable public health resources during the containment phase, should local clusters emerge in their population.
T118 12043-12343 Sentence denotes In addition, prompt sharing of information on cases and contacts through international notification systems such as the International Health Regulations (IHR) mechanism and the European Commission’s European Early Warning and Response System is essential to contain international spread of infection.
T119 12344-12403 Sentence denotes All of the imported cases had a history of travel to China.
T120 12404-12632 Sentence denotes This was consistent with the epidemiological situation in Asia, and supported the recommendation for testing of suspected cases with travel history to China and potentially other areas of presumed ongoing community transmission.
T121 12633-12863 Sentence denotes The situation has evolved rapidly since then, however, and the number of countries reporting COVID-19 transmission increased rapidly, notably with a large outbreak in northern Italy with 3,089 cases reported as at 5 March [18,19].
T122 12864-13231 Sentence denotes Testing of suspected cases based on geographical risk of importation needs to be complemented with additional approaches to ensure early detection of local circulation of COVID-19, including through testing of severe acute respiratory infections in hospitals irrespectively of travel history as recommended in the WHO case definition updated on 27 February 2020 [21].
T123 13232-13332 Sentence denotes The clinical presentation observed in the cases in Europe is that of an acute respiratory infection.
T124 13333-13481 Sentence denotes However, of the 31 cases with information on symptoms, 20 cases presented with fever and nine cases presented only with fever and no other symptoms.
T125 13482-13675 Sentence denotes These findings, which are consistent with other published case series, have prompted ECDC to include fever among several clinical signs or symptoms indicative for the suspected case definition.
T126 13676-13715 Sentence denotes Three cases were aged 65 years or over.
T127 13716-13792 Sentence denotes All required admission to intensive care and were tourists (imported cases).
T128 13793-14068 Sentence denotes These findings could reflect the average older age of the tourist population compared with the local contacts exposed to infection in Europe and do not allow us to draw any conclusion on the proportion of severe cases that we could expect in the general population of Europe.
T129 14069-14307 Sentence denotes Despite this, the finding of older individuals being at higher risk of a severe clinical course is consistent with the evidence from Chinese case series published so far although the majority of infections in China have been mild [22,23].
T130 14308-14416 Sentence denotes This preliminary analysis is based on the first reported cases of COVID-19 cases in the WHO European Region.
T131 14417-14552 Sentence denotes Given the small sample size, and limited completeness for some variables, all the results presented should be interpreted with caution.
T132 14553-14835 Sentence denotes With increasing numbers of cases in Europe, data from surveillance and investigations in the region can build on the evidence from countries in Asia experiencing more widespread transmission particularly on disease spectrum and the proportion of infections with severe outcome [22].
T133 14836-14963 Sentence denotes Understanding the infection-severity is critical to help plan for the impact on the healthcare system and the wider population.
T134 14964-15053 Sentence denotes Serological studies are vital to understand the proportion of cases who are asymptomatic.
T135 15054-15181 Sentence denotes Hospital-based surveillance could help estimate the incidence of severe cases and identify risk factors for severity and death.
T136 15182-15318 Sentence denotes Established hospital surveillance systems that are in place for influenza and other diseases in Europe may be expanded for this purpose.
T137 15319-15530 Sentence denotes In addition, a number of countries in Europe are adapting and, in some cases, already using existing sentinel primary care based surveillance systems for influenza to detect community transmission of SARS-CoV-2.
T138 15531-15786 Sentence denotes This approach will be used globally to help identify evidence of widespread community transmission and, should the virus spread and containment no longer be deemed feasible, to monitor intensity of disease transmission, trends and its geographical spread.
T139 15787-16053 Sentence denotes Additional research is needed to complement surveillance data to build knowledge on the infectious period, modes of transmission, basic and effective reproduction numbers, and effectiveness of prevention and case management options also in settings outside of China.
T140 16054-16290 Sentence denotes Such special studies are being conducted globally, including a cohort study on citizens repatriated from China to Europe, with the aim to extrapolate disease incidence and risk factors for infection in areas with community transmission.
T141 16291-16443 Sentence denotes Countries together with ECDC and WHO, should use all opportunities to address these questions in a coordinated fashion at the European and global level.
T142 16445-16461 Sentence denotes Acknowledgements
T143 16462-16779 Sentence denotes We are grateful for the essential work of a large number of public health experts, clinical microbiologists, practitioners and clinicians who have been involved in the investigations at national and regional level including all the professionals of the Canarian Health Service and the Balearic Islands Health Service.
T144 16780-16963 Sentence denotes We acknowledge the work of ECDC data manager, particularly Zsolt Bartha, and country cooperation teams in rapidly establishing the online reporting system in TESSy by 26 January 2020.
T145 16964-17073 Sentence denotes We thank also the efforts of Catalin Albu, Adrian Prodan, Skaidra Kurapkiene, Per Rolfhamre and Anca Dragnea.
T146 17074-17186 Sentence denotes ECDC also thanks the Epidemic Intelligence team that provides vital and timely data on global cases of COVID-19.
T147 17187-17330 Sentence denotes WHO thanks Ka Yeung (Calvin) Cheng, Silviu Ciobanu, Gudrun Freidl, Lauren MacDonald, and Miriam Sneiderman for assistance with data management.
T148 17331-17349 Sentence denotes Funding statement:
T149 17350-17370 Sentence denotes No specific funding.
T150 17371-17575 Sentence denotes The authors alone are responsible for the views presented in this manuscript and they do not necessarily reflect the views, decisions or policies of the institutions with which the authors are affiliated.
T151 17577-17598 Sentence denotes Conflict of interest:
T152 17599-17613 Sentence denotes None declared.
T153 17614-17705 Sentence denotes Authors’ contributions: EB and BC developed the surveillance system and reporting protocol.
T154 17706-17794 Sentence denotes GS, JB, EB, CA, NB and BC initiated and developed the initial outline of the manuscript.
T155 17795-17821 Sentence denotes GS performed the analysis.
T156 17822-17885 Sentence denotes GS, BC, JB, NB, CA, EB wrote the first draft of the manuscript.
T157 17886-17974 Sentence denotes JF, PJ, DP, JP, RP, SO contributed extensively to additional versions of the manuscript.
T158 17975-18275 Sentence denotes MD, CC, VE, AG, AB, PS, MJSM, ANR, YVD, RoM, MBr, MBe, SBu, JS, LF, ALe, CS, AM, DLB, BC, SBS, SBe, SvdW, MV, BL, FR, EN, IC, ALa, MSC, FP, RiM, CM, MVR, NB, LS, SJ, KTW, MP were involved in national clinical, microbiological and public health investigations as well as data collection and reporting.
T159 18276-18392 Sentence denotes All authors provided input to the outline, multiple versions of the manuscript and gave approval to the final draft.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 589-598 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T2 6601-6606 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T3 6623-6628 Phenotype denotes Cough http://purl.obolibrary.org/obo/HP_0012735
T4 6669-6678 Phenotype denotes Headaches http://purl.obolibrary.org/obo/HP_0002315
T5 6694-6705 Phenotype denotes Sore throat http://purl.obolibrary.org/obo/HP_0033050
T6 6748-6767 Phenotype denotes Shortness of breath http://purl.obolibrary.org/obo/HP_0002098
T7 8380-8385 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T8 8399-8404 Phenotype denotes cough http://purl.obolibrary.org/obo/HP_0012735
T9 8472-8481 Phenotype denotes headaches http://purl.obolibrary.org/obo/HP_0002315
T10 8493-8504 Phenotype denotes sore throat http://purl.obolibrary.org/obo/HP_0033050
T11 8527-8546 Phenotype denotes shortness of breath http://purl.obolibrary.org/obo/HP_0002098
T12 8552-8559 Phenotype denotes myalgia http://purl.obolibrary.org/obo/HP_0003326
T13 8565-8574 Phenotype denotes diarrhoea http://purl.obolibrary.org/obo/HP_0002014
T14 8583-8589 Phenotype denotes nausea http://purl.obolibrary.org/obo/HP_0002018
T15 8595-8600 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T16 8758-8779 Phenotype denotes respiratory infection http://purl.obolibrary.org/obo/HP_0011947
T17 9103-9110 Phenotype denotes dyspnea http://purl.obolibrary.org/obo/HP_0002094
T18 9301-9310 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T19 13087-13109 Phenotype denotes respiratory infections http://purl.obolibrary.org/obo/HP_0011947
T20 13310-13331 Phenotype denotes respiratory infection http://purl.obolibrary.org/obo/HP_0011947
T21 13412-13417 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T22 13453-13458 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T23 13583-13588 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945

2_test

Id Subject Object Predicate Lexical cue
32156327-32046815-29326676 3314-3315 32046815 denotes 9
32156327-32070465-29326677 3754-3756 32070465 denotes 10
32156327-32046819-29326678 4639-4641 32046819 denotes 11

MyTest

Id Subject Object Predicate Lexical cue
32156327-32046815-29326676 3314-3315 32046815 denotes 9
32156327-32070465-29326677 3754-3756 32070465 denotes 10
32156327-32046819-29326678 4639-4641 32046819 denotes 11